Other languages Avecho Biotechnology Limited

Equities

AVE

AU0000047441

Market Closed - Australian S.E. Other stock markets 07:10:18 01/07/2024 BST			5-day change	1st Jan Change
0.002 ^AUD	-33.33%		-33.33%	-42.86%

05-16	Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial	MT
03-25	Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug	03-14
Avecho Biotechnology Secures Ethics Clearance for Phase Three Insomnia Trial	03-07
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-29
Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
Avecho Biotechnology Signs Licensing Deal with Arthur Group for Development of Cancer Drugs	22/05/23
Avecho Biotechnology Raises AU$2 Million Via Entitlement Offer; Shares Slip 20%	09/05/23
Avecho Biotechnology Conducts Entitlement Offer to Raise $11 Million to Fund Pivotal Phase Iii Clinical Trial	03/04/23
Avecho Biotechnology Limited Auditor Raises 'Going Concern' Doubt	14/03/23
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Avecho Biotechnology Expands Research Partnership for Cannabidiol Medication	22/02/23
Avecho Biotechnology Limited Announces Ongoing Collaboration with Lambert Initiative	21/02/23
Athenex Pharmaceutical Division Submits Avecho's Vitamin K Injection to US FDA	12/01/23
Athenex Submits Avecho's Phytonadione to FDA Pre-IND	12/01/23
Avecho Biotechnology Secures Ethics Approval for Phase 3 Insomnia Trial	22/12/22
Avecho Biotechnology Limited Receives Ethics Approval for its Pivotal Phase III Clinical Trial Testing its Oral CBD Softgel Capsule for Insomnia	21/12/22
Avecho Biotechnology Signs Development Deal for TPM-enhanced Ibuprofen Gel for US market; Shares Up 10%	20/12/22
Avecho Biotechnology Limited Signs Development Agreement with Perrigo Company plc	19/12/22
Avecho Biotechnology Limited Announces Interim Results from Comparative Pharmacokinetic Studies Conducted in the Uk	19/09/22
Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Avecho Biotechnology Validates Efficacy of CBD Topical Gel Product in Hand Osteoarthritis Study; Shares Jump 8%	29/03/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Avecho Biotechnology Limited

Equities

AVE

AU0000047441

Other languages

Filters